| ERK1/2 MAP kinases: structure, function, and regulation R Roskoski Jr Pharmacological research 66 (2), 105-143, 2012 | 1906 | 2012 |
| The ErbB/HER family of protein-tyrosine kinases and cancer R Roskoski Jr Pharmacological research 79, 34-74, 2014 | 1449 | 2014 |
| Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update R Roskoski Jr Pharmacological research 152, 104609, 2020 | 1097 | 2020 |
| [1] Assays of protein kinase R Roskoski Jr Methods in enzymology 99, 3-6, 1983 | 978 | 1983 |
| Vascular endothelial growth factor (VEGF) signaling in tumor progression R Roskoski Jr Critical reviews in oncology/hematology 62 (3), 179-213, 2007 | 852 | 2007 |
| Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes R Roskoski Jr Pharmacological research 103, 26-48, 2016 | 794 | 2016 |
| Src protein–tyrosine kinase structure and regulation R Roskoski Jr Biochemical and biophysical research communications 324 (4), 1155-1164, 2004 | 775 | 2004 |
| Src kinase regulation by phosphorylation and dephosphorylation R Roskoski Jr Biochemical and biophysical research communications 331 (1), 1-14, 2005 | 757 | 2005 |
| The ErbB/HER receptor protein-tyrosine kinases and cancer R Roskoski Jr Biochemical and biophysical research communications 319 (1), 1-11, 2004 | 609 | 2004 |
| Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors R Roskoski Jr Pharmacological research 94, 9-25, 2015 | 564 | 2015 |
| A historical overview of protein kinases and their targeted small molecule inhibitors R Roskoski Jr Pharmacological research 100, 1-23, 2015 | 558 | 2015 |
| Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor R Roskoski Jr Biochemical and biophysical research communications 356 (2), 323-328, 2007 | 485 | 2007 |
| RAF protein-serine/threonine kinases: structure and regulation R Roskoski Jr Biochemical and biophysical research communications 399 (3), 313-317, 2010 | 477 | 2010 |
| Properties of FDA-approved small molecule protein kinase inhibitors R Roskoski Jr Pharmacological research 144, 19-50, 2019 | 475 | 2019 |
| Adenosine cyclic 3', 5'-monophosphate dependent protein kinase: kinetic mechanism for the bovine skeletal muscle catalytic subunit PF Cook, ME Neville Jr, KE Vrana, FT Hartl, R Roskoski Jr Biochemistry 21 (23), 5794-5799, 1982 | 466 | 1982 |
| Structure and regulation of Kit protein-tyrosine kinase—the stem cell factor receptor R Roskoski Jr Biochemical and biophysical research communications 338 (3), 1307-1315, 2005 | 425 | 2005 |
| Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers R Roskoski Jr Pharmacological research 139, 395-411, 2019 | 398 | 2019 |
| Rapid protein kinase assay using phosphocellulose-paper absorption JJ Witt, R Roskoski Jr Analytical biochemistry 66 (1), 253-258, 1975 | 397 | 1975 |
| Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases R Roskoski Jr Pharmacological research 111, 784-803, 2016 | 372 | 2016 |
| Signaling by Kit protein-tyrosine kinase—the stem cell factor receptor R Roskoski Jr Biochemical and biophysical research communications 337 (1), 1-13, 2005 | 348 | 2005 |
